IRadimed Corp
NASDAQ:IRMD
IRadimed Corp
NASDAQ:IRMD
Price:
101.04
USD
1.23%
Market Cap:
$1.3B
Balance Sheet
Balance Sheet Decomposition
IRadimed Corp
IRadimed Corp
Balance Sheet Decomposition is not available for
IRadimed Corp
IRadimed Corp
Balance Sheet
IRadimed Corp
IRadimed Corp
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
2
|
2
|
9
|
19
|
18
|
18
|
28
|
43
|
50
|
62
|
58
|
50
|
52
|
51
|
|
| Cash Equivalents |
2
|
2
|
9
|
19
|
18
|
18
|
28
|
43
|
50
|
62
|
58
|
50
|
52
|
51
|
|
| Short-Term Investments |
0
|
0
|
8
|
8
|
8
|
8
|
6
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
2
|
4
|
4
|
4
|
6
|
9
|
7
|
8
|
14
|
12
|
11
|
0
|
|
| Accounts Receivables |
2
|
2
|
2
|
4
|
4
|
4
|
4
|
7
|
5
|
5
|
13
|
12
|
11
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
2
|
2
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
13
|
10
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
25
|
30
|
|
| Total Current Assets |
5
|
6
|
22
|
34
|
34
|
35
|
45
|
59
|
64
|
76
|
77
|
76
|
75
|
81
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
5
|
5
|
5
|
5
|
11
|
17
|
24
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
5
|
5
|
5
|
5
|
11
|
17
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
5
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
3
|
4
|
|
| Total Assets |
6
N/A
|
7
+26%
|
23
+233%
|
35
+51%
|
37
+6%
|
39
+5%
|
48
+24%
|
67
+38%
|
71
+7%
|
83
+17%
|
86
+3%
|
92
+8%
|
98
+7%
|
109
+11%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
3
|
3
|
3
|
4
|
0
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
11
|
3
|
8
|
|
| Total Current Liabilities |
2
|
1
|
2
|
3
|
4
|
4
|
5
|
6
|
5
|
7
|
9
|
16
|
9
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
5
|
5
|
4
|
3
|
4
|
3
|
4
|
|
| Total Liabilities |
2
N/A
|
2
-33%
|
2
+55%
|
3
+37%
|
5
+60%
|
6
+15%
|
7
+7%
|
11
+72%
|
10
-14%
|
11
+11%
|
12
+11%
|
21
+75%
|
12
-45%
|
14
+23%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
3
|
5
|
13
|
20
|
20
|
27
|
36
|
38
|
47
|
47
|
43
|
57
|
0
|
|
| Additional Paid In Capital |
2
|
2
|
16
|
19
|
12
|
13
|
15
|
19
|
24
|
25
|
26
|
28
|
30
|
0
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
87
|
95
|
|
| Total Equity |
3
N/A
|
5
+68%
|
21
+285%
|
32
+53%
|
32
0%
|
33
+3%
|
42
+27%
|
56
+32%
|
61
+11%
|
72
+18%
|
74
+2%
|
71
-3%
|
87
+22%
|
95
+9%
|
|
| Total Liabilities & Equity |
6
N/A
|
7
+26%
|
23
+233%
|
35
+51%
|
37
+6%
|
39
+5%
|
48
+24%
|
67
+38%
|
71
+7%
|
83
+17%
|
86
+3%
|
92
+8%
|
98
+7%
|
109
+11%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
10
|
10
|
11
|
11
|
11
|
11
|
11
|
12
|
12
|
13
|
13
|
13
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
